Slawomir Dziedzic, PhD

Principal Scientist @ Montai Therapeutics

Country

United States

City

Boston

Industry

Venture Capital & Private Equity

Skill

Molecular & Cellular Biology, Assay Development, Research Skills, Life Sciences, Data Analysis, Research Projects, Contract Management, Contract Research Organization (CRO), Strategy, Microbiology, Molecular Biology, Protein Expression, Protein Purification, Immunofluorescence, Enzyme Assays, RT-PCR, RNA isolation, Cell Biology, Cell Culture, Genomics

Experience

Principal Scientist

Montai Therapeutics

2024-7 - Present · 2 yrs 3 mos

Associate Director, Discovery Biology

Nido Biosciences

2022-6 - 2024-5 · 2 yrs

Cambridge, Massachusetts, United States

Principal Scientist, Program Lead

Nido Biosciences

2020-10 - 2022-6 · 1 yr 9 mos

Cambridge, Massachusetts, United States

Senior Scientist, Checkpoint Immunity Cluster

Sanofi

2020-5 - 2020-10 · 6 mos

Cambridge, Massachusetts, United States

Scientist, Checkpoint Immunity Cluster

Sanofi

2018-8 - 2020-4 · 1 yr 9 mos

Cambridge, USA

Postdoctoral Fellow in Cell Biology

Harvard Medical School

2012-1 - 2018-7 · 6 yrs 7 mos

Boston MA

Identified novel potential therapeutic agents for neurodegenerative diseases. I executed cell-based high throughput screen, identified and validated hits and investigated mode of action using both in vitro and in vivo approach. This project was carried out in close collaboration with UCB, Inc. Dissected the role of necroptosis in neurodegenerative diseases that have an inflammatory component (AD, ALS). Identified and characterized key proteins and biomarkers responsible for RIP1K post-translational modification and their impact on inflammatory disorders and schizophrenia.

PhD Candidate

University of Idaho

2007-6 - 2011-12 · 4 yrs 7 mos

Moscow ID

Investigated the molecular basis of zinc-induced necrotic cell death (ziNCD) and its relationship to autophagocytosis in Saccharomyces cerevisiae. Characterized changes in cell death pathways resulting from the expression PSMA and its yeast and plant analogue. Dissecting novel PSMA function using Saccharomyces cerevisiae as a model organism.